Skip to main content
. 2018 Aug 6;9(17):3109–3116. doi: 10.7150/jca.25235

Figure 3.

Figure 3

The prognostic significance of miR-302b and EphA2 in stage IV GC patients. The Kaplan-Meier analysis of overall survival for patients with low and high expression of miR-302b and EphA2 groups in the training (A, B) and validation cohorts(C, D).